Microbes, monitors, and miraculous medicine converge in this week’s roundup of research-related headlines at Children’s Hospital of Philadelphia. Keep reading to learn more about new concerns for commercially available baby monitors reported by our researchers, one family’s inspirational story of resilience and recovery after their baby daughter battled a brain tumor, and exciting upcoming events in the CHOP community, including the fifth annual symposium for microbiome research.
Tag Archive: Infants
Researchers from the Children’s Oncology Group (COG) have developed a new standardized dosing method for anticancer drugs in infants to use across all COG clinical trials. This unified method, based on dose banding and organized into tables for different drugs and dose levels, will address the limitations and variability that researchers can encounter in current methods.
More mothers are breastfeeding than ever before. However, getting breastfeeding going can be difficult. Babies with inherited metabolic disorders, such as medium-chain acyl-CoA dehydrogenase deficiency (let’s just call it MCAD) can be especially vulnerable to low blood sugar if they aren’t getting enough milk in the early days of breastfeeding.
Every week is full of discovery at The Children’s Hospital of Philadelphia. Among the highlights this week are a significant discovery and new treatment option in a heart surgery complication that affects young patients; a study of how to predict infants’ later obesity risk; and a CHOP cancer immunotherapy story hitting the world stage at an international conference.
Investigators at The Children’s Hospital of Philadelphia are on the cusp of an innovative approach to caring for preterm babies, one that could radically transform the way they are treated and significantly improve their outcomes.
The most common underlying diagnoses related to ALTEs are gastroesophageal reflux and upper respiratory illness. Clinicians also consider cardiac causes, but no standardized method is used to evaluate patients with ALTEs, especially with regard to electrocardiograms (ECGs) as a diagnostic tool.
Children who are later diagnosed with an autism spectrum disorder have subtle but measurable differences in attention as early as 7 months of age, a new study shows. Infants who went on to be diagnosed with autism are slower to shift their gaze from one object to another, according to the researchers, who identified specific brain circuits that seem to cause the slower response.